ORIC Pharmaceuticals

(NASDAQ) ORIC

Current Price$9.53

Market Cap$979.28M

Since IPO (2020)-63%

5 Year-49%

1 Year-9%

1 Month+11%

ORIC Pharmaceuticals Financials at a Glance

Market Cap

$979.28M

Revenue (TTM)

$0.00

Net Income (TTM)

-$135.21M

EPS (TTM)

-$1.43

P/E Ratio

-6.61

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Price

$9.53

Volume

113,153

Open

$9.50

Price

$9.53

Volume

113,153

Open

$9.50

Previous Close

$9.53

Daily Range

$9.28 - $9.73

52-Week Range

$7.23 - $14.93

Estimated Earnings Date

Aug 11, 2026

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Price

$9.53

Volume

113,153

Open

$9.50

Previous Close

$9.53

Daily Range

$9.28 - $9.73

52-Week Range

$7.23 - $14.93

Estimated Earnings Date

Aug 11, 2026

ORIC News

research scientists drugs pharma biotech

Why Shares of Oric Pharmaceuticals Jumped Monday

James HalleyJun 26, 2023

Why ORIC Pharmaceuticals Stock Is Crashing Today

Keith SpeightsMar 22, 2022

Will Last Week's Biotech IPO Outperform in a Recession?

David HaenApr 28, 2020

ORIC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ORIC Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

104

CEO

Jacob M. Chacko, MD, MBA

Website

www.oricpharma.com

Headquarters

South San Francisco, CA 94080, US

ORIC Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-35.33%

Return on Capital

-36.12%

Return on Assets

-30.96%

Earnings Yield

-15.13%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$979.28M

Shares Outstanding

103.52M

Volume

113.15K

Avg. Volume

1.91M

Financials (TTM)

Gross Profit

-$320.00K

Operating Income

-$149.91M

EBITDA

-$134.03M

Operating Cash Flow

-$110.88M

Capital Expenditure

-$487.00K

Free Cash Flow

-$111.36M

Cash & ST Invst.

$281.93M

Total Debt

$3.30M

ORIC Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$979.28M

N/A

Market Cap/Employee

$8.03M

N/A

Employees

122

N/A

Net Income

-$35.77M

-19.1%

EBITDA

-$35.50M

-19.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$281.93M

+38.4%

Total Debt

$3.30M

+2.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$3.30M

+2.6%

Return on Assets

-30.96%

N/A

Return on Invested Capital

-35.78%

N/A

Free Cash Flow

-$32.44M

+2.2%

Operating Cash Flow

-$32.44M

+1.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TRMLTourmaline Bio, Inc.

TRMLTourmaline Bio, Inc.$47.98+0.00%

NKTRNektar Therapeutics

NKTRNektar Therapeutics$63.65+2.61%

INBXInhibrx Biosciences Inc.

INBXInhibrx Biosciences Inc.$94.81-0.52%

AMLXAmylyx Pharmaceuticals, Inc.

AMLXAmylyx Pharmaceuticals, Inc.$17.79+2.01%

PGENPrecigen, Inc.

PGENPrecigen, Inc.$5.86+6.16%

SNDXSyndax Pharmaceuticals, Inc.

SNDXSyndax Pharmaceuticals, Inc.$21.31+7.57%

ATAIAtai Beckley Inc.

ATAIAtai Beckley Inc.$5.29+15.50%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.87+0.02%

ONDSOndas

ONDSOndas$7.83+0.02%

KEELKeel Infrastructure

KEELKeel Infrastructure$6.03+0.03%

HLHecla Mining

HLHecla Mining$15.54+0.03%

SOFISoFi Technologies

SOFISoFi Technologies$17.88+0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67+0.04%

TAT&T

TAT&T$22.72+0.01%

Questions About ORIC

What is the current price of ORIC Pharmaceuticals?

ORIC Pharmaceuticals is trading at $9.53 per share.

What is the 52-week range for ORIC Pharmaceuticals?

Over the past 52 weeks, ORIC Pharmaceuticals has traded between $7.23 and $14.93.

How much debt does ORIC Pharmaceuticals have?

As of the most recent reporting period, ORIC Pharmaceuticals reported total debt of $3.30M.

How much cash does ORIC Pharmaceuticals have on hand?

ORIC Pharmaceuticals reported $56.40M in cash and cash equivalents in its most recent financial results.

What is ORIC Pharmaceuticals’s dividend yield?

ORIC Pharmaceuticals does not currently have a dividend yield.

ORIC Pharmaceuticals

ORIC Pharmaceuticals Financials at a Glance

ORIC News

Why Shares of Oric Pharmaceuticals Jumped Monday

Why ORIC Pharmaceuticals Stock Is Crashing Today

Will Last Week's Biotech IPO Outperform in a Recession?

ORIC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About ORIC Pharmaceuticals

ORIC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

ORIC Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ORIC

What is the current price of ORIC Pharmaceuticals?

What is the 52-week range for ORIC Pharmaceuticals?

How much debt does ORIC Pharmaceuticals have?

How much cash does ORIC Pharmaceuticals have on hand?

What is ORIC Pharmaceuticals’s dividend yield?

Premium Investing Services